Corneal Collagen Cross-linking (CXL) with Riboflavin

Type: procedure

Status: FDA Approved (Avedro KXL System)

Developer: Dresden University of Technology, Germany

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026